For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

FP358

4649

Dr.Amulya Das
Membership No Author Name Email Mobile
4649 Dr.Amulya Das dasgau01@gmail.com 9600026276
Neuro Ophthalmology

Ptosis in a Child with ALL: Recognizing Vincristine-Induced Neuropathy

Aim:To highlight isolated ptosis as a rare, reversible manifestation of vincristine-induced neuropathy in childhood acute lymphoblastic leukemia emphasizing early diagnosis, drug interactions, and timely management.
Methods: 10-year-old child with ALL developed unilateral ptosis four weeks after weekly vincristine therapy. Ophthalmic examination revealed 6/6 vision, normal colour vision, full ocular movements, severe left ptosis with levator underaction, normal pupils, & normal anterior & posterior segments. Ice-pack test was negative. The child was also receiving voriconazole, a CYP3A4 inhibitor that potentiates vincristine neurotoxicity. Vincristine-induced cranial neuropathy was diagnosed. Vincristine was stopped & pyridoxine with pyridostigmine was started.
Conclusion: Ptosis resolved completely within two weeks, vincristine restarted. Early recognition of vincristine neurotoxicity & its interaction with voriconazole enables prompt treatment and continuation of chemotherapy.

Membership No Author Name Email Mobile
1219 Dr.Chinmayee Thrishulamurthy chinmayee.jt@gmail.com 9483504425
165 Dr.Nagaraju G nagarajug63@gmail.com 9845011294